Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.150
+0.050 (4.55%)
At close: May 13, 2025, 4:00 PM
1.150
0.00 (0.00%)
Pre-market: May 14, 2025, 7:01 AM EDT
PACB Revenue
Pacific Biosciences of California had revenue of $37.15M in the quarter ending March 31, 2025, a decrease of -4.27%. This brings the company's revenue in the last twelve months to $152.36M, down -23.99% year-over-year. In the year 2024, Pacific Biosciences of California had annual revenue of $154.01M, down -23.19%.
Revenue (ttm)
$152.36M
Revenue Growth
-23.99%
P/S Ratio
2.12
Revenue / Employee
$264,969
Employees
575
Market Cap
345.10M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 154.01M | -46.51M | -23.19% |
Dec 31, 2023 | 200.52M | 72.22M | 56.29% |
Dec 31, 2022 | 128.30M | -2.21M | -1.69% |
Dec 31, 2021 | 130.51M | 51.62M | 65.43% |
Dec 31, 2020 | 78.89M | -12.00M | -13.20% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
PACB News
- 1 day ago - PacBio Board Independent Investigation Concludes Allegations Unsubstantiated - GlobeNewsWire
- 5 days ago - Pacific Biosciences of California, Inc. (PACB) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - PacBio Announces First Quarter 2025 Financial Results - GlobeNewsWire
- 8 days ago - First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand - GlobeNewsWire
- 15 days ago - PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry - GlobeNewsWire
- 21 days ago - Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa - GlobeNewsWire
- 4 weeks ago - PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million - GlobeNewsWire
- 5 weeks ago - PacBio Grants Equity Incentive Award to New Employee - GlobeNewsWire